Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Vaccinations01:51

Vaccinations

51.3K
Overview
51.3K
Structures of Solids02:22

Structures of Solids

17.5K
Solids in which the atoms, ions, or molecules are arranged in a definite repeating pattern are known as crystalline solids. Metals and ionic compounds typically form ordered, crystalline solids. A crystalline solid has a precise melting temperature because each atom or molecule of the same type is held in place with the same forces or energy. Amorphous solids or non-crystalline solids (or, sometimes, glasses) which lack an ordered internal structure and are randomly arranged. Substances that...
17.5K
Metallic Solids02:37

Metallic Solids

20.5K
Metallic solids such as crystals of copper, aluminum, and iron are formed by metal atoms. The structure of metallic crystals is often described as a uniform distribution of atomic nuclei within a “sea” of delocalized electrons. The atoms within such a metallic solid are held together by a unique force known as metallic bonding that gives rise to many useful and varied bulk properties.
All metallic solids exhibit high thermal and electrical conductivity, metallic luster, and malleability....
20.5K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

574
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
574
Internal Receptors01:31

Internal Receptors

74.3K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.3K
Network Covalent Solids02:18

Network Covalent Solids

16.1K
Network covalent solids contain a three-dimensional network of covalently bonded atoms as found in the crystal structures of nonmetals like diamond, graphite, silicon, and some covalent compounds, such as silicon dioxide (sand) and silicon carbide (carborundum, the abrasive on sandpaper). Many minerals have networks of covalent bonds.
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
16.1K
  1. ホーム
  2. ワクチンによる固体腫瘍に対するcar-t細胞活性強化
  1. ホーム
  2. ワクチンによる固体腫瘍に対するcar-t細胞活性強化

関連する実験動画

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models
06:22

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Published on: February 2, 2024

4.8K

ワクチンによる固体腫瘍に対するCAR-T細胞活性強化

Leyuan Ma1,2, Tanmay Dichwalkar1, Jason Y H Chang1

  • 1David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Science (New York, N.Y.)
|July 13, 2019

PubMed で要約を見る

まとめ
この要約は機械生成です。

この研究では,キメリック抗原受容体-T細胞 (CAR-T) 治療のための新しいワクチン強化方法が導入されています. アンフィフィルのCAR- Tリガンドは,CAR- T細胞の機能と固体腫瘍に対する抗腫瘍効果を高めます.

さらに関連する動画

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.9K
Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
07:33

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

760

関連する実験動画

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models
06:22

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Published on: February 2, 2024

4.8K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.9K
Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
07:33

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

760

科学分野:

  • 免疫療法
  • 腫瘍学
  • バイオテクノロジー

背景:

  • 化学抗原受容体-T細胞 (CAR-T) 治療は,血液がんの治療に有望である.
  • CAR- T治療は固体腫瘍に対する有効性が限られている.

研究 の 目的:

  • 固体腫瘍に対する CAR- T 細胞の機能と有効性を高めるため
  • CAR-T細胞に対する新しい in vivo ワクチン強化戦略を開発する.

主な方法:

  • リンパ節を標的としたアンフィフィール型CAR-Tリガンド (アンフリガンド)
  • 抗原を提示する細胞と原始CAR-T細胞を in situで装飾するために,アンフリガンドを投与した.
  • 免疫能力のあるマウスモデルにおけるCAR- T細胞の膨張,多機能性,および抗腫瘍活性を評価した.

主要な成果:

  • アムフリガンド投与は,CAR-T細胞の大規模な膨張につながった.
  • CAR- T細胞の多機能性と抗腫瘍効果の改善が前臨床モデルで示された.
  • 既存のCAR-Tデザインに適用可能な汎用化戦略を示した.

結論:

  • 固体腫瘍におけるCAR- T治療の限界を克服するための有望な戦略です.
  • このアプローチは,広範囲の臨床適用のためにCAR-Tの機能性を高めるために,単純な非ヒト白血球抗原制限方法を提供します.